Santa Barbara Surgery Center is First in Southern California to Adopt New Wireless Technology for Arthroscopy

CLEVELAND–(BUSINESS WIRE)–#Biomedevice–De La Vina Surgicenter in Santa Barbara, CA, and medical device and technology company Lazurite® announced that De La Vina is the first healthcare center in Southern California to adopt Lazurite’s new ArthroFree® Wireless Surgical Camera System. De La Vina has used it for a variety of knee, shoulder, and other arthroscopic procedures.




“Our facility was designed to give each patient the ultimate experience in same-day surgical procedures with unrivaled quality of care and state-of-the-art technology,” said De La Vina Surgicenter physician Christopher S. Proctor, M.D. “We’ve been impressed by the ArthroFree System. Not having wires around makes for a safer and more efficient operating room. The staff loves it because it’s quicker to set up and take down. I think wireless is the future.”

“We are proud to have De La Vina Surgicenter embrace the use of the ArthroFree system,” Lazurite CEO and cofounder Eugene Malinskiy said. “The simplicity and ease of use of the system are demonstrated by the quick adoption of wireless arthroscopy by De Le Vina.”

Dr. Proctor specializes in sports medicine, shoulder, knee and arthroscopic surgery. He is the team physician for the University of California, Santa Barbara Baseball team and the Santa Barbara Foresters baseball team of the California Collegiate League. He is also a staff physician for University of California, Santa Barbara, and provides sports medicine care for numerous high school, collegiate and professional athletes.

Lazurite helps surgeons stay focused under pressure when it is most critical. With the new wireless ArthroFree system, there are no cords to distract a surgeon’s attention so they can maintain their full concentration on the patient’s procedure. ArthroFree has been used in centers of excellence with outstanding results. For more information, contact a product expert at: (833) 214-2324 or [email protected].

About Lazurite

Lazurite designs medtech devices. Its ArthroFree® System is the first wireless camera with FDA clearance for arthroscopy and general endoscopy. The ArthroFree System is designed to enhance the surgeon’s focus during the critical moments of surgery by enabling untethered movement and dexterity. It promises to increase the safety and efficiency of minimally invasive surgical procedures while decreasing the cost. Lazurite’s IP portfolio includes the high-efficiency Meridiem® light technology, wireless communication technology, and products in development. Lazurite’s three-year vision (by 2026): Modernize 1,000 operating rooms for the wireless age. For more information, see https://lazurite.co.

Forward-Looking Statements

This press release includes “forward-looking statements.” Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “projected,” “estimate,” “expect,” “may,” “should,” “will,” “designed,” “optimistic,” “promises,” “helps,” “allows” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the expected impact and ease of use advantages of the ArthroFree System within the field of minimally invasive surgery, particularly orthopedic surgery. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Lazurite®, ArthroFree®, and Meridiem® are registered trademarks of Lazurite Holdings LLC.

Media Center

Visit lazurite.co/media for videos, logos, images, fact sheets, bios and more.

Contacts

Lazurite:

Patrick Gallagher

+1 (216) 233-7473

[email protected]

+1 (833) 214-4234

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.